Large NUCL stake: sponsor for Eagle Nuclear Energy (NUCL) details shares and warrants
Rhea-AI Filing Summary
Eagle Nuclear Energy Corp. disclosed that Spring Valley Acquisition Sponsor II, LLC, a 10% owner, holds 2,408,335 shares of common stock and 9,422,133 private warrants for common stock. The warrants have an exercise price of $11.50 per share, become exercisable on March 26, 2026, and expire on February 24, 2031, unless redeemed earlier.
The common shares were received in a merger-related exchange for an equal number of founder shares of Spring Valley Acquisition Corp. II. The private warrants were received through settlement of working capital loans, a related sponsor agreement, and an exchange of existing SVII warrants. The securities are held directly by the sponsor, which is controlled by Christopher Sorrells; he and the sponsor may be deemed 10% owners but each disclaims beneficial ownership beyond their pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Private Warrants | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Pursuant to that certain Amended and Restated Agreement and Plan of Merger (the "Merger Agreement"), dated as of September 29, 2025, by and among Eagle Nuclear Energy Corp. (the "Issuer"), Spring Valley Acquisition Corp. II ("SVII"), Eagle Energy Metals Corp., Spring Valley Merger Sub III, Inc., and Spring Valley Merger Sub II, Inc., Spring Valley Acquisition Sponsor II, LLC (the "Sponsor") received 2,408,335 of the Issuer's common stock, par value $0.01 per share ("Common Stock"), in exchange for the 2,408,335 SVII Class B founder shares, par value $0.001 per share, that the Sponsor held, prior to the effective time of the merger. The reported securities are held directly by the Sponsor. The Sponsor is controlled by Mr. Christopher Sorrells. Accordingly, all of the shares held by the Sponsor may be deemed to be beneficially held by Mr. Sorrells. Each reporting person under this Form 3 disclaims beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein and the filing of this Form 3 shall not be construed as an admission that any such reporting person is the beneficial owner of any such securities. Each warrant will become exercisable on March 26, 2026. Each warrant will expire on February 24, 2031, or earlier upon redemption. Pursuant to the Merger Agreement, the Sponsor received (i) 1,500,000 of the Issuer's private warrants in settlement of outstanding working capital loans; (ii) 922,133 additional private warrants pursuant to a Sponsor Agreement related to the Merger Agreement; and (iii) 7,000,000 private warrants in exchange for 7,000,000 SVII warrants at an exercise price of $11.50 per share, that the Sponsor held.